Direkt zum Inhalt
Merck
  • Attenuated PDGF signaling drives alveolar and microvascular defects in neonatal chronic lung disease.

Attenuated PDGF signaling drives alveolar and microvascular defects in neonatal chronic lung disease.

EMBO molecular medicine (2017-09-20)
Prajakta Oak, Tina Pritzke, Isabella Thiel, Markus Koschlig, Daphne S Mous, Anita Windhorst, Noopur Jain, Oliver Eickelberg, Kai Foerster, Andreas Schulze, Wolfgang Goepel, Tobias Reicherzer, Harald Ehrhardt, Robbert J Rottier, Peter Ahnert, Ludwig Gortner, Tushar J Desai, Anne Hilgendorff
ZUSAMMENFASSUNG

Neonatal chronic lung disease (nCLD) affects a significant number of neonates receiving mechanical ventilation with oxygen-rich gas (MV-O

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Gelatine -Lösung, Type B, 2% in H2O, tissue culture grade, BioReagent, suitable for cell culture